OBSIDIAN CIO, LLC

Position in ABBV — AbbVie Inc.

CIK 1843581 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$601,671

+$168,431 QoQ

Shares Held

2,391

+20.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.80%

of 13F equity value

Holder Rank

#3,003

of 4,153 holders

Holding Since

Mar 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

OBSIDIAN CIO, LLC holds $12,058,485 across 9 Drug Manufacturers - General names. ABBV ranks #3 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	18,327	$6,636,573
2	NVO	Novo Nordisk A S	73,106	$3,504,701
3	ABBV	AbbVie Inc. This page	2,391	$601,671
4	JNJ	Johnson & Johnson	2,245	$570,162
5	LLY	ELI LILLY & Co	436	$522,951
6	MRK	Merck & Co., Inc.	1,376	$176,816
7	PFE	Pfizer Inc	1,249	$30,075
8	GILD	Gilead Sciences, Inc.	102	$12,886

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$601,671	2,391	+20.0%	Shares	Sole	2026-08-03
2026-03-31	$433,240	1,992	+57.5%	Shares	Sole	2026-05-11
2025-12-31	$289,039	1,265	-58.6%	Shares	Sole	2026-02-18
2025-09-30	$706,891	3,053	+44.6%	Shares	Sole	2025-10-21
2025-06-30	$392,029	2,112	-1.4%	Shares	Sole	2025-08-07
2025-03-31	$448,582	2,141	+20.1%	Shares	Sole	2025-05-05
2024-12-31	$316,661	1,782	+22.7%	Shares	Sole	2025-02-11
2024-09-30	$286,740	1,452	-4.3%	Shares	Sole	2024-11-04
2024-06-30	$260,195	1,517	-6.4%	Shares	Sole	2024-07-26
2024-03-31	$295,184	1,621	+0.8%	Shares	Sole	2024-04-30
2023-12-31	$249,191	1,608	+1.1%	Shares	Sole	2024-02-02
2023-09-30	$237,154	1,591	+7.9%	Shares	Sole	2023-11-01
2023-03-31	$235,070	1,475	-2.6%	Shares	Sole	2023-05-12
2022-12-31	$244,677	1,514	+15.7%	Shares	Sole	2023-02-09
2022-06-30	$200,333	1,308	+0.9%	Shares	Sole	2022-08-08
2022-03-31	$210,094	1,296	—	Shares	Sole	2022-05-06
No filing history on record for this holder in this stock.